Ultime notizie per Silicom (NASDAQ:SILC) Azioni

Silicom

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

Silicom Ltd

Growth in 2025 is expected to be in the low single digits, with strong 20%-30% compound annual growth rate materializing gradually from 2026.

News

Guidance

SILC

Reported Earlier, Silicom Projects Q4 Revenues Of $14M - $15M (Est $14.635M); Growth In 2025 Is Expected To Be In The Low Single Digits

Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.32) by 12.5 percent. The company reported quarterly sales of $14.756 which missed the analyst consensus estimate of $14.518 million by 100.00 percent. This is a 100.00 percent decrease over sales of $30.057 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Silicom Q3 2024 Adj. EPS $(0.28) Beats $(0.32) Estimate, Sales $14.756 Miss $14.518M Estimate

Needham analyst Alex Henderson downgrades Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) from Buy to Hold.

Downgrades

Analyst Ratings

Needham Downgrades Silicom to Hold

WIIM

Silicom shares are trading lower after the company reported worse-than-expected Q2 revenue results.

Silicom Sees Q3 Revenues $14M-$15M

Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.35) by 60 percent. The company reported quarterly sales of $14.502 million which missed the analyst consensus estimate of $15.252 million by 4.92 percent. This is a 61.97 percent decrease over sales of $38.130 million the same period last year.

Silicom Q2 2024 Adj EPS $(0.14) Beats $(0.35) Estimate, Sales $14.502M Miss $15.252M Estimate

Needham analyst Alex Henderson reiterates Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) with a Buy and maintains $20 price target.

Price Target

Reiteration

Needham Reiterates Buy on Silicom, Maintains $20 Price Target

Share Repurchase Plan
In addition, the Company today announced that its Board of Directors has authorized a new one-year share buyback plan allowing the Company to invest up to $15 million to repurchase its ordinary shares. This plan will take effect as soon as the previously-announced $15 million one-year plan is completed. The timing and actual number of shares repurchased will depend upon a variety of factors, including share market price and general business and market conditions. The plan authorizes management to repurchase ordinary shares using a variety of methods, including open market transactions in compliance with the rules of the US Securities and Exchange Commission and other applicable legal requirements. Repurchases will be funded from available working capital. The plan does not obligate Silicom to buy back any specific number of shares and may be suspended or terminated at any time at Management's discretion. Management notes that its cash balance provides sufficient working capital and financial flexibility to weather the current environment while completing the Company's current share buyback program and carrying out this new one.

Buybacks

Silicom Board Of Directors Has Authorized A New One-year Share Buyback Plan Allowing The Company To Invest Up To $15M To Repurchase Its Ordinary Shares

Guidance
Management projects that revenues for the second quarter of 2024 will range from $15 million to $17 million. We believe that excess customer inventories and global economy headwinds will ease moving forward through 2024, resulting in second half revenues that are higher than those of the first half, and full-year revenues of approximately $70 million.

Silicom Sees Q2 Revenue $15M-$17M; FY24 Revenue ~$70M

Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.23) by 65.22 percent. This is a 162.3 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $14.37 million which missed the analyst consensus estimate of $16.73 million by 14.14 percent. This is a 61.36 percent decrease over sales of $37.18 million the same period last year.

Silicom Q1 Adj $(0.38) Misses $(0.23) Estimate, Sales $14.37M Miss $16.73M Estimate

Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.03) by 133.33 percent. The company reported quarterly sales of $18.80 million which missed the analyst consensus estimate of $20.00 million by 6.00 percent. This is a 58.40 percent decrease over sales of $45.19 million the same period last year.

Silicom Q4 2023 Adj EPS $(0.07) Misses $(0.03) Estimate, Sales $18.80M Miss $20.00M Estimate

AAPL

ALGM

AMZN

ATKR

BALL

BrightSphere Investment Group plc Ordinary Shares

BSIG

CLFD

COLM

COUR

CSWI

CVCO

DECK

ENSG

EVBN

EXPO

FCFS

FLWS

GOOS

HOLX

HUBG

Janus Henderson Group plc Ordinary Shares

KMPR

LANC

LESL

LPLA

MATW

MCHP

MIXT

MTSI

OCSL

ONEW

OTEX

PFSI

POST

PTON

RACE

RVTY

SHEL

SIRI

SKYW

SRDX

TEAM

TECH

TSCO

VIAV

Earnings Scheduled For February 1, 2024

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to <a href="https://www.benzinga.com/topic/stock-whisper-index">uncover new information.</a>
Benzinga&rsquo;s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks each week that are just under the surface and warrant attention.
The index layers editorial commentary to help make sense of why these stocks should be of interest and whether investors and casual readers should watch them. Here is a look at the Benzinga Stock Whisper Index for the week of Oct. 27, 2023:
Impinj Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>): The semiconductor stock saw increased interest from investors after <a href="https://investor.impinj.com/news/press-release/2023/Impinj-Reports-Third-Quarter-2023-Financial-Results/default.aspx">reporting </a>third quarter financial results and sharing fourth quarter guidance. The company&rsquo;s revenue and earnings per share each beat consensus estimates from analysts.
&ldquo;We see early signs of retail demand improvement, strong ongoing endpoint IC unit-volume growth despite the downturn and remain optimistic for the future,&rdquo; Impinj CEO Chris Diorio said.
Multiple <a href="https://www.benzinga.com/quote/PI/analyst-ratings">analysts remained bullish</a> on the stock, with Buy ratings going forward. Several analysts did lower the price targets on the stock. Price targets of $85, $95 and $89 from Needham, Roth MKM and Goldman Sachs remain higher than the current share price of around $62.
ABVC Biopharma Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>): The $5 million biopharmaceutical company finds its way on the list after <a href="https://www.benzinga.com/news/23/10/35439641/what-in-the-world-is-going-on-with-abvc-biopharma-stock">seeing shares soar during the week. </a>The move came after the company announced a term sheet to license the global rights of CNS drugs to AiBtl BioPharma. The drugs have indications that target Major Depressive Disorder (MDD) and Attention Deficit Hyperactivity Disorder (ADHD). ABVC will receive stock in AiBtl, milestone payments and potential royalties from products launched.
First Foundation Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ffwm#NYSE">FFWM</a>): The investment and financial planning company <a href="https://investor.ff-inc.com/news/news-details/2023/First-Foundation-Inc.-Reports-Third-Quarter-2023-Financial-Results/default.aspx">reported </a>third quarter financial results during the week and saw shares trade higher on the results. Third quarter revenue of $63.77 million and earnings per share of 5 cents beat consensus estimates of $63.64 million and 4 cents respectively.
Silicom (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silc#NASDAQ">SILC</a>): Shares of the data infrastructure company fell after reporting third quarter financial results. The company&rsquo;s revenue of $30.06 million beat a Street consensus estimate of $29.76 million. Earnings per share also beat the analysts&rsquo; estimate. Weaker fourth quarter guidance was not well received by investors. The company said it expects fourth quarter revenue in a range of $20 million to $21 million, versus a Street consensus estimate of $31.63 million. After a challenging fiscal 2024, the company said it expects to return to double-digit growth in fiscal 2025.
Related Link: <a href="https://www.benzinga.com/quote/SILC/analyst-ratings">Analyst Ratings For Silicom&nbsp;</a>
Align Technology (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algn#NASDAQ">ALGN</a>): The owner of clear aligners and the Invisalign brand <a href="https://www.benzinga.com/news/earnings/23/10/35432987/why-orthodontics-company-align-technology-shares-are-plummeting-today">saw shares fall</a> after reporting third quarter financial results, with revenue and earnings per share each missing estimates from analysts. The company reported revenue growth of 7.8% year-over-year in the third quarter, and Clear Aligner revenue was up 8.5% year-over-year. Guidance from the company for the fourth quarter also came in lower than estimates from analysts. The company announced it will repurchase up to $250 million in shares in the fourth quarter as part of a 2023 stock repurchase program.
&ldquo;Our third quarter results reflect lower than expected demand and a more difficult macro environment than we experienced in the first half of 2023,&rdquo; Align CEO Joe Hogan said.
The earnings report from Align Technology comes after the company&rsquo;s competitor SmileDirectClub<a href="https://www.benzinga.com/news/23/09/35017733/smiledirectclub-files-for-chapter-11-bankruptcy-just-four-years-after-1-35-billion-ipo"> filed for Chapter 11 bankruptcy.</a>
Read Next:<a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks"> Best Artificial Intelligence Stocks&nbsp;</a>
Check out the most recent Stock Whisper reports here:
<a href="https://www.benzinga.com/general/biotech/23/10/35126757/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-ye">Oct. 6&nbsp;</a>
<a href="https://www.benzinga.com/markets/penny-stocks/23/10/35241169/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Oct. 13</a>
<a href="https://www.benzinga.com/markets/penny-stocks/23/10/35350340/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Oct. 20</a>
Stay tuned for next week&rsquo;s report, and follow Benzinga Pro for all the latest headlines and<a href="https://pro.benzinga.com/feature/newsfeed/?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348"> top market-moving stories here.</a>

Analyst Color

Penny Stocks

Small Cap

Exclusives

Trading Ideas

ABVC

ALGN

FFWM

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Needham analyst Alex Henderson maintains Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) with a Buy and lowers the price target from $28 to $22.

Needham Maintains Buy on Silicom, Lowers Price Target to $22

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Thursday.
The Dow traded down 0.29% to 32,938.92 while the NASDAQ fell 1.33% to 12,650.31. The S&amp;P 500 also fell, dropping, 0.77% to 4,154.47.
Check This Out: <a href="https://www.benzinga.com/news/23/10/35436564/meta-to-rally-over-42-here-are-10-top-analyst-forecasts-for-thursday"> Meta To Rally Over 42%? Here Are 10 Top Analyst Forecasts For Thursday </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Real estate shares rose by 1.9% on Thursday.
In trading on Thursday, communication services shares dipped by 3%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Mastercard Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ma#NYSE">MA</a>) reported better-than-expected earnings for its third quarter.
Net revenues stood at $6.53 billion, up 14% Y/Y and 11% Y/Y on a neutral currency basis, beating the consensus of $6.52 billion. Adjusted EPS rose 26% Y/Y to $3.39, exceeding the consensus of $3.21.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) shares shot up 170% to $2.2950 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million.
Shares of Endeavor Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/edr#NYSE">EDR</a>) got a boost, shooting 24% to $21.99 after the company announced a review of strategic alternatives.
Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) shares were also up, gaining 20% to $59.78 after the company reported better-than-expected third-quarter revenue results.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares dropped 79% to $0.0965 as the company reported pricing of $5.04 million registered direct offering.
Shares of Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) were down 51% to $0.1820 as the company announced pricing of $1.7 million public offering of 8.5 million shares of common stock at a price of $0.20 per share.
Silicom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silc#NASDAQ">SILC</a>) was down, falling 34% to $14.75 after the company issued weak sales forecast for the fourth quarter.
Also Check This Out:<a href="https://www.benzinga.com/news/23/10/35437319/kimberly-clark-roblox-and-2-other-stocks-insiders-are-selling"> Kimberly-Clark, Roblox And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 2.5% to $83.26 while gold traded up 0.2% at $1,997.90.
Silver traded down 0.4% to $22.905 on Thursday while copper fell 0.1% to $3.5860.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.48%, London&rsquo;s FTSE 100 fell 0.81% while Spain&rsquo;s IBEX 35 Index fell 0.24% The German DAX dipped 1.08% French CAC 40 slipped 0.38%, while Italy&rsquo;s FTSE MIB Index rose 0.29%.
The European Central Bank held interest rates during its October meeting. Spain&#39;s unemployment rate rose to 11.84% in the third quarter from 11.60% in the prior three-month period. UK car production surged 39.8% year-over-year to 88,230 units in September.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Thursday, with Japan&rsquo;s Nikkei 225 falling 2.14%, Hong Kong&rsquo;s Hang Seng Index declining 0.24% and China&rsquo;s Shanghai Composite Index gaining 0.48%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell around 1.4%.
Hong Kong&rsquo;s trade deficit increased to $64.6 billion in September from $44.9 billion in the year-ago month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The U.S. economy grew an annualized 4.9% in the third quarter, higher than market expectations of 4.3% and compared to a 2.1% growth in the second quarter.
U.S. initial jobless claims increased by 10,000 to 210,000 in the week ending Oct. 21, above market estimates of 208,000.
U.S. durable goods orders rose by 4.7% month-over-month in September versus a 0.1% decline in August and topping market estimates of a 1.7% rise.
The U.S. trade deficit in goods rose to $85.8 billion in September versus a revised $84.6 billion gap in the prior month.
Wholesale inventories in the U.S. came in unchanged month-over-month during September, compared to a 0.1% decline in the previous month.
The Kansas City Fed&rsquo;s Manufacturing Production index rose to a reading of -8 in October compared to prior month&rsquo;s level of -13.
U.S. natural gas supplies climbed 74 billion cubic feet last week, the EIA said.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35435946/top-5-real-estate-stocks-that-could-lead-to-your-biggest-gains-in-october"> Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains in October</a>

Eurozone

Commodities

Global

Intraday Update

Markets

BETS

SNOA

Crude Oil Down 2.5%; Mastercard Posts Upbeat Earnings

<h3>Gainers</h3>
<ul>
<li>ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) shares jumped 231.6% to $2.8190 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) gained 77.8% to $0.3074. PaxMedica reported the completion of a type-B meeting with the FDA.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares surged 36.3% to $0.6250 after falling 21% on Wednesday. NextPlay Technologies received a notice from Nasdaq regarding delayed second-quarter report.</li>
<li>Mustang Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbio#NASDAQ">MBIO</a>) gained 33% to $2.1009. Mustang Bio announced FDA acceptance of IND application for MB-109, a novel combination of MB-101 and MB-108, for the treatment of recurrent glioblastoma and high-grade astrocytoma.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) jumped 31.6% to $0.3450. Mullen received favorable decision from Nasdaq Hearings Panel.</li>
<li>Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) gained 31% to $65.06 after the company reported better-than-expected third-quarter revenue results.</li>
<li>The Singing Machine Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mics#NASDAQ">MICS</a>) gained 30% to $0.91.</li>
<li>Meta Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmat#NASDAQ">MMAT</a>) rose 28.6% to $0.1662.</li>
<li>Appreciate Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfr#NASDAQ">SFR</a>) shares climbed 26.8% to $0.1530 after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting.</li>
<li>La Rosa Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrhc#NASDAQ">LRHC</a>) gained 25% to $1.9499. La Rosa launched its proprietary AI technology system &#39;JAEME&#39; to support real estate agents.</li>
<li>Twin Ridge Capital Acquisition Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trca#NYSE">TRCA</a>) rose 24% to $9.27.</li>
<li>Bel Fuse Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/belfb#NASDAQ">BELFB</a>) jumped 23.4% to $48.61 after the company reported third-quarter financial results.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) gained 22.8% to $74.44.</li>
<li>Endeavor Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/edr#NYSE">EDR</a>) rose 22.2% to $21.65 after the company announced a review of strategic alternatives.</li>
<li>Jaguar Global Growth Corporation I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jggc#NASDAQ">JGGC</a>) shares climbed 21.7% to $8.01 after gaining over 18% on Wednesday.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 21.7% to $1.92. The FDA accepted ImmunityBio&#39;s resubmission of its Biologics License Application for N-803 as complete.</li>
<li>First Foundation Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ffwm#NYSE">FFWM</a>) rose 20.7% to $5.91 following upbeat quarterly results.</li>
<li>ProSomnus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osa#NASDAQ">OSA</a>) gained 19.7% to $0.7185.</li>
<li>Blueprint Medicines Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpmc#NASDAQ">BPMC</a>) gained 19.4% to $52.49 following strong quarterly results.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) rose 17.6% to $0.7876 after dipping 14% on Wednesday.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) jumped 17.3% to $9.40 following third-quarter results.</li>
<li>NETGEAR, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntgr#NASDAQ">NTGR</a>) rose 15.5% to $12.05 after the company reported better-than-expected third-quarter financial results.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) gained 15% to $0.4271. TransCode Therapeutics announced prolonged survival in murine models with glioblastoma treated with its lead candidate, TTX-MC138.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) rose 14.5% to $0.1382.</li>
<li>Sonic Automotive, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sah#NYSE">SAH</a>) gained 12.8% to $48.92 following better-than-expected quarterly results.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) climbed 12.5% to $5.02 following third-quarter results.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) gained 12.3% to $0.9996.</li>
<li>Mangoceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgrx#NASDAQ">MGRX</a>) shares jumped 12% to $0.8399 after falling around 14% on Wednesday. Mangoceuticals recently announced the official launch of MangoRx affiliate marketing program to enhance and accelerate topline growth.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) gained 12.1% to $206.23 following strong quarterly results.</li>
<li>Morningstar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/morn#NASDAQ">MORN</a>) rose 11.1% to $244.57 following third-quarter results.</li>
<li>Heidrick &amp; Struggles International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsii#NASDAQ">HSII</a>) rose 10.5% to $25.47 after the company reported better-than-expected quarterly financial results.</li>
<li>Willis Towers Watson Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtw#NASDAQ">WTW</a>) gained 10.3% to $229.11 after the company reported better-than-expected third-quarter results.</li>
<li>Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) jumped 8.4% to $9.73. Healthcare Services recently reported financial results.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) rose 7.8% to $11.52 after the company reported better-than-expected third-quarter revenue results. Additionally, the company raised FY23 revenue guidance above estimates.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares fell 78.9% to $0.0970 as the company reported pricing of $5.04 million registered direct offering.</li>
<li>Sight Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sght#NASDAQ">SGHT</a>) dipped 53.3% to $1.6850. Sight Sciences is expected to report financial results for the third quarter on Nov. 7, 2023.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) fell 48.7% to $0.1901 as the company announced pricing of $1.7 million public offering of 8.5 million shares of common stock at a price of $0.20 per share.</li>
<li>Silicom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silc#NASDAQ">SILC</a>) fell 35.4% to $14.35 after the company issued weak sales forecast for the fourth quarter.</li>
<li>Lipella Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lipo#NASDAQ">LIPO</a>) declined 30.2% to $1.18.</li>
<li>SunCar Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sda#NASDAQ">SDA</a>) declined 29.9% to $8.10 after the company announced a $21 million follow-on offering of 2,567,238 shares at $8.18 per share.</li>
<li>LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) fell 29.4% to $0.1201.</li>
<li>BIO-key International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkyi#NASDAQ">BKYI</a>) declined 25.8% to $0.1706.</li>
<li>Nuvve Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvve#NASDAQ">NVVE</a>) fell 24.7% to $0.1799. Nuvve announced pricing of $2.066 million registered direct offering priced at-the-market.</li>
<li>Align Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algn#NASDAQ">ALGN</a>) fell 23.4% to $194.34 after the company reported worse-than-expected third-quarter financial results and issued guidance.</li>
<li>Theratechnologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thtx#NASDAQ">THTX</a>) shares fell 20.3% to $1.02 as the company reported pricing of $25 million public offering of common shares and concurrent private placement.</li>
<li>MaxLinear, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mxl#NASDAQ">MXL</a>) fell 17% to $15.28 after reporting downbeat results for the third quarter. Roth MKM downgraded MaxLinear from Buy to Neutral and lowered the price target from $35 to $18.</li>
<li>Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhat#NASDAQ">BHAT</a>) shares fell 16.2% to $2.28 after jumping over 33% on Wednesday. Fujian Blue Hat Interactive Entertainment Technology recently filed for a mixed shelf of up to $150 million.</li>
<li>Cognition Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgtx#NASDAQ">CGTX</a>) shares fell 15.7% to $1.0784 after gaining over 5% on Wednesday.</li>
<li>Whirlpool Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/whr#NYSE">WHR</a>) dropped 14.4% to $107.49 after the company reported third-quarter financial results and issued FY23 EPS guidance below estimates.</li>
<li>Expro Group Holdings N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpro#NYSE">XPRO</a>) declined 14.5% to $17.21 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Western Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wdc#NASDAQ">WDC</a>) fell 14% to $36.26. Western Digital and Kioxia called off memory merger talks, Nikkei Asia reported.</li>
<li>Valmont Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vmi#NYSE">VMI</a>) declined 13.4% to $200.22 after the company reported third-quarter financial results and narrowed FY23 EPS guidance. Additionally, the company announced a realignment program and offered headcount reductions.</li>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares fell 11.7% to $0.4369. Akili is expected to report its financial and operating results for the third quarter on Nov. 9, 2023.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htz#NASDAQ">HTZ</a>) declined 11.8% to $8.93 after the company reported worse-than-expected third quarter adjusted EPS results.</li>
<li>Simulations Plus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slp#NASDAQ">SLP</a>) declined 11.7% to $34.53 after the company reported worse-than-expected quarterly revenue results.</li>
<li>Hasbro, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/has#NASDAQ">HAS</a>) fell 11.3% to $48.58 after the company reported worse-than-expected third-quarter financial results and said it expects FY23 revenue decline.</li>
<li>Celestica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cls#NYSE">CLS</a>) declined 10.8% to $22.56. The company reported third-quarter financial results and issued FY23 guidance.</li>
<li>The Western Union Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wu#NASDAQ">WU</a>) declined 10.8% to $11.53. The company issued third-quarter financial results and narrowed FY23 adjusted EPS guidance.</li>
<li>Harley-Davidson, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hog#NYSE">HOG</a>) dropped 9.6% to $26.03 after the company reported worse-than-expected quarterly revenue results.</li>
<li>Oceaneering International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oii#NYSE">OII</a>) declined 9.6% to $21.81 following weak quarterly sales.</li>
<li>West Pharmaceutical Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wst#NYSE">WST</a>) declined 9.5% to $323.99 following weak quarterly sales.</li>
<li>Mattel, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mat#NASDAQ">MAT</a>) shares fell 8.1% to $18.48 after reporting third-quarter results.</li>
<li>IM Cannabis Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) shares fell 8% to $0.55.</li>
<li>Comcast Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NASDAQ">CMCSA</a>) declined 6.4% to $40.03 after the company reported third-quarter financial results.</li>
<li>The Trade Desk, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttd#NASDAQ">TTD</a>) fell 6.1% to $67.30.</li>
<li>Meta Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meta#NASDAQ">META</a>) fell 2.3% to $292.55. Meta reported better-than-expected results for its third quarter. The company said it sees fourth-quarter revenue coming in a range of $36.5 billion to $40 billion.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35435755/more-than-246m-bet-on-occidental-petroleum-check-out-these-4-stocks-insiders-are-buying"> More Than $246M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying </a>

Movers

AIRE

AKLI

BELFB

BHAT

BKYI

BPMC

CANO

CGTX

CMCSA

HCSG

HSII

IBRX

IMCC

JGGC

LIPO

LMDX

LRHC

MBIO

MGRX

MICS

MMAT

MORN

MULN

NOVA

NTGR

NVVE

NXTP

OPRA

PXMD

RNAZ

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SGHT

SWVL

THTX

TRCA

XPRO

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Thursday.
The Dow traded down 0.36% to 32,918.38 while the NASDAQ fell 1.12% to 12,677.56. The S&amp;P 500 also fell, dropping, 0.65% to 4,159.52.
Check This Out: <a href="https://www.benzinga.com/news/23/10/35436564/meta-to-rally-over-42-here-are-10-top-analyst-forecasts-for-thursday"> Meta To Rally Over 42%? Here Are 10 Top Analyst Forecasts For Thursday </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Real estate shares rose by 2.2% on Thursday.
In trading on Thursday, communication services shares dipped by 2%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The U.S. economy grew an annualized 4.9% in the third quarter, higher than market expectations of 4.3% and compared to&nbsp;2.1% growth in the second quarter.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) shares shot up 159% to $2.2057 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million.
Shares of Endeavor Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/edr#NYSE">EDR</a>) got a boost, shooting 23% to $21.75 after the company announced a review of strategic alternatives.
Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) shares were also up, gaining 26% to $62.53 after the company reported better-than-expected third-quarter revenue results.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares dropped 79% to $0.0983 as the company reported pricing of $5.04 million registered direct offering.
Shares of Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) were down 50% to $0.1861 as the company announced pricing of $1.7 million public offering of 8.5 million shares of common stock at a price of $0.20 per share.
Silicom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silc#NASDAQ">SILC</a>) was down, falling 35% to $14.38 after the company issued weak sales forecast for the fourth quarter.
Also Check This Out:<a href="https://www.benzinga.com/news/23/10/35437319/kimberly-clark-roblox-and-2-other-stocks-insiders-are-selling"> Kimberly-Clark, Roblox And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.7% to $83.97 while gold traded down 0.3% at $1,989.80.
Silver traded down 0.8% to $22.82 on Thursday while copper rose 0.2% to $3.5970.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.28%, London&rsquo;s FTSE 100 fell 0.64% while Spain&rsquo;s IBEX 35 Index fell 0.13% The German DAX dipped 0.82% French CAC 40 slipped 0.14%, while Italy&rsquo;s FTSE MIB Index rose 0.52%.
The European Central Bank held interest rates during its October meeting. Spain&#39;s unemployment rate rose to 11.84% in the third quarter from 11.60% in the prior three-month period. UK car production surged 39.8% year-over-year to 88,230 units in September.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Thursday, with Japan&rsquo;s Nikkei 225 falling 2.14%, Hong Kong&rsquo;s Hang Seng Index declining 0.24% and China&rsquo;s Shanghai Composite Index gaining 0.48%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell around 1.4%.
Hong Kong&rsquo;s trade deficit increased to $64.6 billion in September from $44.9 billion in the year-ago month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The U.S. economy grew an annualized 4.9% in the third quarter, higher than market expectations of 4.3% and compared to a 2.1% growth in the second quarter.
U.S. initial jobless claims increased by 10,000 to 210,000 in the week ending Oct. 21, above market estimates of 208,000.
U.S. durable goods orders rose by 4.7% month-over-month in September versus a 0.1% decline in August and topping market estimates of a 1.7% rise.
The U.S. trade deficit in goods rose to $85.8 billion in September versus a revised $84.6 billion gap in the prior month.
Wholesale inventories in the U.S. came in unchanged month-over-month during September, compared to a 0.1% decline in the previous month.
The Kansas City Fed&rsquo;s Manufacturing Production index rose to a reading of -8 in October compared to prior month&rsquo;s level of -13.
U.S. natural gas supplies climbed 74 billion cubic feet last week, the EIA said.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35435946/top-5-real-estate-stocks-that-could-lead-to-your-biggest-gains-in-october"> Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains in October</a>

Dow Dips Over 100 Points; US GDP Growth Tops Expectations

Silicom shares are trading lower after the company issued Q4 revenue guidance below estimates.

U.S. stocks traded mixed this morning, following the release of several economic reports.
Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to 12,790.71. The S&amp;P 500 also fell, dropping, 0.13% to 4,181.15.
Check This Out: <a href="https://www.benzinga.com/news/23/10/35436564/meta-to-rally-over-42-here-are-10-top-analyst-forecasts-for-thursday"> Meta To Rally Over 42%? Here Are 10 Top Analyst Forecasts For Thursday </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Real estate shares rose by 1% on Thursday.
In trading on Thursday, communication services shares dipped by 2%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Bristol Myers Squibb &amp; Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmy#NYSE">BMY</a>) reported better-than-expected earnings for its third quarter.
Bristol Myers Squibb said revenues came in at $10.966 billion, due to lower sales of Revlimid, partially offset by in-line products and its new product portfolio. Analysts were expecting sales of $10.965 billion. Adjusted EPS rose 1% year-over-year to $2.00, beating the consensus of $1.76.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) shares shot up 220% to $2.72 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million.
Shares of PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) got a boost, shooting 82% to $0.3146. PaxMedica reported the completion of a type-B meeting with the FDA.
Appreciate Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfr#NASDAQ">SFR</a>) shares were also up, gaining 45% to $0.1751 after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares dropped 70% to $0.1380 as the company reported pricing of $5.04 million registered direct offering.
Shares of Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) were down 51% to $0.18 as the company announced pricing of $1.7 million public offering of 8.5 million shares of common stock at a price of $0.20 per share.
Silicom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silc#NASDAQ">SILC</a>) was down, falling 29% to $15.82 after the company issued weak sales forecast for the fourth quarter.
Also Check This Out:<a href="https://www.benzinga.com/news/23/10/35437319/kimberly-clark-roblox-and-2-other-stocks-insiders-are-selling"> Kimberly-Clark, Roblox And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 2.7% to $83.09 while gold traded down 0.2% at $1,991.20.
Silver traded down 0.1% to $23.00 on Thursday while copper rose 0.3% to $3.6030.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 0.5%, London&rsquo;s FTSE 100 fell 0.5% while Spain&rsquo;s IBEX 35 Index fell 0.5% The German DAX dipped 1% French CAC 40 slipped 0.4%, while Italy&rsquo;s FTSE MIB Index fell 0.1%.
The European Central Bank held interest rates during its October meeting. Spain&#39;s unemployment rate rose to 11.84% in the third quarter from 11.60% in the prior three-month period. UK car production surged 39.8% year-over-year to 88,230 units in September.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Thursday, with Japan&rsquo;s Nikkei 225 falling 2.14%, Hong Kong&rsquo;s Hang Seng Index declining 0.24% and China&rsquo;s Shanghai Composite Index gaining 0.48%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell around 1.4%.
Hong Kong&rsquo;s trade deficit increased to $64.6 billion in September from $44.9 billion in the year-ago month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The U.S. economy grew an annualized 4.9% in the third quarter, higher than market expectations of 4.3% and compared to a 2.1% growth in the second quarter.
U.S. initial jobless claims increased by 10,000 to 210,000 in the week ending Oct. 21, above market estimates of 208,000.
U.S. durable goods orders rose by 4.7% month-over-month in September versus a 0.1% decline in August and topping market estimates of a 1.7% rise.
The U.S. trade deficit in goods rose to $85.8 billion in September versus a revised $84.6 billion gap in the prior month.
Wholesale inventories in the U.S. came in unchanged month-over-month during September, compared to a 0.1% decline in the previous month.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35435946/top-5-real-estate-stocks-that-could-lead-to-your-biggest-gains-in-october"> Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains in October</a>

US Stocks Mixed; Bristol Myers Posts Upbeat Earnings

Guidance
&nbsp;
Given our customers&rsquo; continued draw-down of the high component inventories they built during Covid and persistent macro-economic headwinds, we project that&nbsp;Q4&nbsp;revenues will range between&nbsp;$20&nbsp;and&nbsp;$21 million, and that 2024 as a whole will be challenging. However, we expect to return to double digit growth in 2025.

Silicom Ltd Expects Q4 Revenue of $20M-$21M Vs. $31.63M Est, a Challenging FY24 and Return to Double Digit Growth in FY25

Silicom (SILC – Research Report) received a Hold rating and price target from Needham analyst Alex Henderson today. The company's shares closed yes...

Silicom (SILC) was downgraded to a Hold Rating at Needham

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
With last week&rsquo;s <a href="https://finance.yahoo.com/news/july-jobs-report-unemployment-rate-jumps-to-43-job-gains-total-just-114000-as-labor-slowdown-deepens-190219766.html">dismal jobs report</a> in the back mirror, the S&amp;P 500 is currently off its all-time highs. And, there&rsquo;s fear in the air that the U.S. economy might be in worse shape than anticipated- even as the Federal Reserve is now expected to begin a rate reduction of 0.50%. The result? A sell-off.



When investing in <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a>, it&rsquo;s more important than ever to focus on the fundamentals of the top and bottom lines. 



&ldquo;Growth stocks are those companies expected to grow sales and earnings at a faster rate than the market average,&rdquo; according to <a href="https://www.investopedia.com/terms/g/growthstock.asp">Investopedia</a>. As a result, if (and when) the rug is pulled, companies with poor financials will plummet the fastest. Looking out for growth stocks to sell might be a prudent choice before that happens.



To get my list of stocks for this article, I screened the market using the following criteria.



<ul><li>Earnings growth rate: Negative growth in the latest full-year financials and its latest quarterly report</li>



<li>Revenue growth rate: Negative growth in the latest full-year financials and its latest quarterly report</li>



<li>Analyst rating: Buy or hold</li>



<li>Trading price: Above $10</li>
</ul>Then, I arranged the stocks based on their highest earnings percentage drop, arriving at the top three. The results are somewhat subjective since I scanned for buy- and hold-rated stocks instead of those that are sell-rated. However, a linear decline across yearly and quarterly reports indicates that you might need to sell these growth stocks before the bottom falls out.



<h2>Silicom Ltd. (SILC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/cloud-data-flow-300x169.png" alt="An image of a computer server in a cloud"><div>Source: jossnat/Shutterstock</div></div>Known as a leading provider of high-performance networking and data infrastructure solutions, Silicom Ltd. (NASDAQ:<a href="https://investorplace.com/stock-quotes/silc-stock-quote/">SILC</a>) provides OEMs with solutions for their server and cloud-based systems. Silicom Ltd.&rsquo;s products range from server network interface cards to programmable cards and other stand-alone products. The company operates the sectors of Data storage and big data, Network appliances, Cloud and virtualized data centers, Servers and IoT.



The year of 2023 was a challenge for Silicom Ltd. Revenue slid from <a href="https://www.silicom-usa.com/wp-content/uploads/2024/02/PRQ423.pdf">$150.6 million to $124.1 million</a>. Also, the bottom line turned red, at -44 cents per share, compared to last year&rsquo;s $2.73 profit &ndash; a 116% drop. This prompted the company to announce a five-year strategic plan to reduce expenses and build up its core business.



However, its <a href="https://www.silicom-usa.com/wp-content/uploads/2024/07/PRQ224.pdf">Q2 of fiscal year 2024 results</a> show no signs of recovery, with revenue further sliding from $38.1 million last year to $14.5 million. Meanwhile, the quarter ended with a 25 cent loss, compared to a 56 cent profit in the same quarter last year. Silicom Ltd. attributes the worsening performance to excess customer inventory, longer sales cycles and a slowdown in global demand.



SILC stock is already down 34% year-to-date (YTD) and has a <a href="https://www.nasdaq.com/market-activity/stocks/silc/analyst-research">hold rating</a>. Given Silicom Ltd.&rsquo;s dismal financials, I&rsquo;d make it a contender for any growth stocks to sell list.



<h2>Stepan Company (SCL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/07/cleaning1600-300x169.jpg" alt="Someone cleaning a kitchen table with a spray bottle and towel.. AERC, SNOA Stock"><div>Source: Maridav/ShutterStock.com</div></div>Stepan Company (NYSE:<a href="https://investorplace.com/stock-quotes/scl-stock-quote/">SCL</a>) is a leading chemical producer specializing in intermediate and specialty chemicals used in various products, such as detergents, disinfectants, emulsifiers and more. 



SCL operates in three main segments. The first is Polymers, providing its clients with polyester resins and other polymer-related products. The second is Surfactants, which produces cleaning-related chemicals used in detergents, fabric softeners and more. The third is Specialty Products, which includes emulsifiers, flavorings and solubilizers for pharmaceutical and food applications.



Like the other two growth stocks to sell on this list, SCL&rsquo;s financial performance has declined, highlighting some red flags for the current financial year and beyond.



In 2023, for example, <a href="https://stepan.gcs-web.com/news-releases/news-release-details/stepan-reports-fourth-quarter-and-full-year-2023-results">net sales decreased by 16%</a> year-over-year (YOY), while operating income fell by a massive 72%. Even worse, net income decreased by 73%.&nbsp;



&ldquo;The Company had a challenging 2023 due to a slow down in demand across most end use markets and significant customer and channel inventory destocking,&rdquo; said president and Chief Executive Officer Scott Behrens. &ldquo;While we believe the negative impacts of destocking are mostly behind us, we continue to experience significant destocking within our agricultural business and expect this to continue through the first half of 2024.&rdquo;



True to his word, Q2 FY24&rsquo;s results were lackluster, with net sales and net income dropping by <a href="https://stepan.gcs-web.com/news-releases/news-release-details/stepan-reports-second-quarter-2024-results">10% and 19% YOY</a>, respectively. SCL&rsquo;s top and bottom lines have been battered by rising corporate expenses, lower selling prices and competitive pressure in Latin America.



Executives are cautiously optimistic about their outlook, and analysts rate SCL stock a <a href="https://www.nasdaq.com/market-activity/stocks/scl/analyst-research">buy</a>. But the company&rsquo;s declining metrics might be enough to add it to your sell list.



<h2>Schneider National (SNDR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/supply-chain-shipping-logistics-1600-300x169.png" alt="logistics stocks. supply chain stocks"><div>Source: Travel mania / Shutterstock.com</div></div>Schneider National (NYSE:<a href="https://investorplace.com/stock-quotes/sndr-stock-quote/">SNDR</a>) is a freight and logistics company that operates in three main segments. Truckload provides freight services under long-term contracts that run on consistent routes. Intermodal offers drayage and rail intermodal services to its customers. Finally, Logistics provides transportation systems analysis and additional sources of truck capacity to customers.



Schneider National&rsquo;s FY23 results do not bode well for the company&rsquo;s immediate future. Operating revenues were down <a href="https://investors.schneider.com/news-events/financial-news/news-details/2024/Schneider-National-Inc.-Announces-Fourth-Quarter-2023-Results/default.aspx">17% YOY</a>, while income from operations fell sharply by 51%. Even worse, the company&rsquo;s bottom line fell 48% on GAAP and non-GAAP bases.



More recently, its <a href="https://investors.schneider.com/news-events/financial-news/news-details/2024/Schneider-National-Inc.-Announces-Second-Quarter-2024-Results/default.aspx">Q2 FY24 results</a> are no better (or even worse in some areas). While operating revenue decreased by a mere 5%, increased spending and reduced operating income resulted in a massive 69% contraction in net income.



While Wall Street analysts rate SNDR stock as a <a href="https://www.nasdaq.com/market-activity/stocks/sndr/analyst-research">consensus buy</a>, its shaky fundamentals and deteriorating financials suggest placing it on my growth stocks to sell list.



On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/08/red-flag-alert-3-growth-stocks-to-sell-before-they-go-to-zero/">Red Flag Alert! 3 Growth Stocks to Sell Before They Go to Zero.</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Red Flag Alert! 3 Growth Stocks to Sell Before They Go to Zero.

Warning: SILC is at high risk of performing badly

Silicom (SILC) has released an update. Silicom Ltd., a key player in high-performance networking solutions, is slated to announce its Q3 2024 finan...

Silicom Set to Unveil Q3 2024 Financial Performance

Silicom Q3 2024 Earnings Preview

Silicom Non-GAAP EPS of $0.28 beats by $0.60, revenue of $14.8M beats by $0.28M

Silicom Ltd. 2024 Q3 - Results - Earnings Call Presentation

Silicom Ltd. (SILC) Q3 2024 Earnings Call Transcript

Silicom ( ($SILC) ) has released its Q3 earnings. Here is a breakdown of the information Silicom presented to its investors. Silicom Ltd. is a lead...

Silicom Ltd. Reports Q3 2024 Earnings: Navigating Challenges and Strategic Growth

In a report released today, Ryan Koontz from Needham maintained a Hold rating on Silicom (SILC – Research Report). The company's shares closed last...

Needham Sticks to Its Hold Rating for Silicom (SILC)

SNDR

Press Releases

SILICOM'S FOURTH QUARTER & FULL YEAR 2023 RESULTS RELEASE SCHEDULED FOR FEBRUARY 1, 2024

Comments

Silicom

Notizie

Ultime notizie per Silicom (NASDAQ:SILC) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO